•
Jun 30, 2023

Seres Therapeutics Q2 2023 Earnings Report

Total Revenue
$126M
Previous year: $1.22M
+10300.7%
EPS
$0.36
Previous year: -$0.7
-151.4%
Gross Profit
$124M
Previous year: -$42.7M
-391.1%
Cash and Equivalents
$230M
Previous year: $127M
+81.0%
Free Cash Flow
$64.8M
Previous year: -$52.1M
-224.4%
Total Assets
$406M
Previous year: $273M
+48.8%

Seres Therapeutics

Seres Therapeutics